A detailed history of Guggenheim Capital LLC transactions in Inspire Medical Systems, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 2,284 shares of INSP stock, worth $400,339. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,284
Previous 6,782 66.32%
Holding current value
$400,339
Previous $907,000 46.86%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$125.79 - $216.71 $565,803 - $974,761
-4,498 Reduced 66.32%
2,284 $482,000
Q2 2024

Aug 14, 2024

BUY
$133.83 - $251.19 $53,130 - $99,722
397 Added 6.22%
6,782 $907,000
Q1 2024

May 14, 2024

BUY
$165.3 - $226.0 $105,626 - $144,414
639 Added 11.12%
6,385 $1.37 Million
Q4 2023

Feb 14, 2024

BUY
$125.26 - $203.83 $91,189 - $148,388
728 Added 14.51%
5,746 $1.17 Million
Q3 2023

Nov 14, 2023

BUY
$185.0 - $326.08 $1,295 - $2,282
7 Added 0.14%
5,018 $995,000
Q2 2023

Aug 11, 2023

SELL
$226.52 - $324.64 $93,552 - $134,076
-413 Reduced 7.61%
5,011 $1.63 Million
Q1 2023

May 10, 2023

SELL
$229.06 - $278.01 $123,921 - $150,403
-541 Reduced 9.07%
5,424 $1.27 Million
Q4 2022

Feb 14, 2023

BUY
$164.02 - $259.76 $78,565 - $124,425
479 Added 8.73%
5,965 $1.5 Million
Q3 2022

Nov 14, 2022

BUY
$170.68 - $226.46 $639,025 - $847,866
3,744 Added 214.93%
5,486 $973,000
Q2 2022

Aug 15, 2022

SELL
$147.53 - $266.6 $1,917 - $3,465
-13 Reduced 0.74%
1,742 $318,000
Q1 2022

May 16, 2022

SELL
$193.94 - $261.91 $48,291 - $65,215
-249 Reduced 12.43%
1,755 $451,000
Q4 2021

Feb 14, 2022

BUY
$207.57 - $280.17 $415,970 - $561,460
2,004 New
2,004 $461,000

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.05B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.